ATB Antivirals Overview

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

ATB Antivirals General Information

Description

Developer of a biotechnology platform intended to offer topical therapeutics for diseases associated with the Human Papillomavirus (HPV). The company focuses on formulating and commercializing topical treatments to address the unmet needs concerning genital warts and premalignant infections caused by HPV, enabling patients to get safe and effective treatment options that can improve their quality of life.

Contact Information

Formerly Known As
Anison Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Talvitie 11 as 2
  • 20610 Turku
  • Finland
+358
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Talvitie 11 as 2
  • 20610 Turku
  • Finland
+358

ATB Antivirals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ATB Antivirals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 12-Nov-2026 Completed Pre-Clinical Trials
4. Early Stage VC 28-Nov-2023 Completed Pre-Clinical Trials
3. Debt - General 01-Aug-2022 Completed Pre-Clinical Trials
2. Seed Round 16-Jun-2022 $425K $425K Completed Startup
1. Accelerator/Incubator 01-Jan-2020 Completed Startup
To view ATB Antivirals’s complete valuation and funding history, request access »

ATB Antivirals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view ATB Antivirals’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ATB Antivirals Patents

ATB Antivirals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020296960-A1 Pharmaceutical compositions of ovatodiolide and the use thereof Active 17-Jun-2019
AU-2020296960-B2 Pharmaceutical compositions of ovatodiolide and the use thereof Active 17-Jun-2019
CA-3143889-A1 Pharmaceutical compositions of ovatodiolide and the use thereof Pending 17-Jun-2019
EP-3983083-A1 Pharmaceutical compositions of ovatodiolide and the use thereof Pending 17-Jun-2019
US-12773401-B2 Pharmaceutical compositions of ovatodiolide and the use thereof Active 17-Jun-2019 A61K31/365
To view ATB Antivirals’s complete patent history, request access »

ATB Antivirals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ATB Antivirals Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eir Women's Health Accelerator Accelerator/Incubator
Metsola Ventures Venture Capital Minority
Monttu Ventures Venture Capital Minority
SPARK Finland Accelerator/Incubator
To view ATB Antivirals’s complete investors history, request access »

ATB Antivirals FAQs

  • Where is ATB Antivirals headquartered?

    ATB Antivirals is headquartered in Turku, Finland.

  • What is the size of ATB Antivirals?

    ATB Antivirals has 4 total employees.

  • What industry is ATB Antivirals in?

    ATB Antivirals’s primary industry is Drug Discovery.

  • Is ATB Antivirals a private or public company?

    ATB Antivirals is a Private company.

  • What is ATB Antivirals’s current revenue?

    The current revenue for ATB Antivirals is .

  • How much funding has ATB Antivirals raised over time?

    ATB Antivirals has raised $1.77M.

  • Who are ATB Antivirals’s investors?

    Eir Women's Health Accelerator, Metsola Ventures, Monttu Ventures, and SPARK Finland have invested in ATB Antivirals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process